$252.5 Million and a Korean Subsidiary: How the AMAT Case Resets the Compliance Map for Korea–China Semiconductor Supply Chains

Export Controls & Korea–China

Primary source → BIS AMAT settlement documents (Order + Settlement Agreement + Proposed Charging Letter), 11 February 2026

On 11 February 2026, Applied Materials, Inc. and its Korean subsidiary, Applied Materials Korea (AMK), settled with the U.S. Bureau of Industry and Security for a civil penalty of $252,500,300. The headline traveled fast: a quarter-billion-dollar export-control penalty, the largest of its kind against a U.S. semiconductor-equipment maker. What did not travel was the part that matters most to a Korean supplier — the order is, at its core, a document about Korea. It describes a production line that began in Massachusetts, finished in Pyeongtaek, and shipped to Shanghai, and it explains in operative legal language why a Korean final-assembly step did nothing to remove U.S. jurisdiction.

This piece reads the order, not the recap. If you run compliance at a Korean equipment maker, a Korean subsidiary of a U.S. firm, or a Korean contract manufacturer with U.S.-sourced content and Chinese customers, the five sentences quoted below are the ones to put in front of your CEO.

Executive summary

Between roughly 2020 and 2022, AMAT partially built ion-implant tools in Gloucester, Massachusetts, shipped the partially assembled tools and the parts needed to finish them to AMK in Pyeongtaek, completed assembly and testing there, and shipped the finished tools to SMIC in China — after SMIC was subject first to an “is-informed” license requirement (25 September 2020) and then to the Entity List (18 December 2020). The reexported ion-implant equipment was valued at approximately $126,250,150, classified under ECCN 3B991, and subject to the Export Administration Regulations (EAR) (Order p. 2).

BIS rejected the idea that Korean assembly changed the analysis. Its order states plainly that “substantial transformation” is not the test, that the U.S.-origin items remained subject to the EAR, and that moving assembly offshore for a single restricted customer was itself the violation. AMAT — a company with an established compliance program and over 1,100 prior license applications — paid the statutory maximum, accepted a three-year suspended denial order conditioned on its named CEA/CEO no longer being employed in that role, agreed to two annual compliance audits (reports due 1 July 2027 and 1 July 2028), and waived its statute-of-limitations defense with tolling that runs as late as 11 February 2029.

For Korea, the case is not a curiosity about one large American firm. It is a template. The three-step “U.S. partial build → Korean completion → China delivery” structure is how a meaningful slice of the Korean equipment supply chain actually operates. The order is, in effect, a map of that exposure.

1. The facts the press did not carry

Three findings elevate this case above a dollar figure.

A compliance program and 1,100 licenses did not mitigate the penalty. The order records that AMAT “has designed, implemented, and maintained an export compliance program tailored to its risk profile and has applied for over 1,100 licenses from BIS,” including “over 100 BIS licenses” for SMIC-related shipments between 2020 and 2022 (Order p. 2). The company nonetheless paid $252,500,300. The lesson for any compliance officer who assumes that a mature program and good-faith licensing on parallel product lines will soften enforcement: here, it did not. BIS treated the deliberate structural workaround on the dual-build stream as the conduct that mattered, and parallel licensing activity did not offset it.

The intent is on the record, verbatim. The order quotes an internal AMAT communication: “suffice to say we need to go into hyper drive on [South] Korea” (Order p. 8). A U.S. government enforcement order reproducing an internal email about accelerating Korean assembly is the clearest possible signal that the purpose of the Korean step — not merely its existence — is what BIS investigated. Any Korean entity whose internal records contain similar language, or instructions from a U.S. parent to expand China-bound assembly scope, should understand those records are discoverable.

The clock does not stop at settlement. AMAT “waives and will not assert any Statute of Limitations defense,” and the limitations period “will be tolled… from the date of the Order until the later of” full penalty payment, completion of both audits, or successful run of the three-year suspension period (Settlement Agreement, ¶4, p. 17). The latest possible tolling end date is 11 February 2029. Prospective SOL tolling tied to audit completion is now a standard BIS settlement term — and it is invisible in the press release.

2. The jurisdictional theory — why Korean assembly did not help

This is the heart of the case, and it rests on a single foundation: 15 C.F.R. § 734.3, the provision that defines which items are “subject to the EAR.” Items physically located in the United States, and U.S.-origin items wherever located, are subject to the EAR. AMAT’s tools began as U.S.-origin items. Finishing them in Korea did not change that.

“Substantial transformation” is not the test. BIS wrote: “‘substantial transformation’ does not appear anywhere in the EAR and is not the correct test for determining whether an item is subject to the EAR because it is an item of U.S. origin” (Order p. 11). This is the single most correctable misunderstanding in the Korean semiconductor supply chain. Korean compliance teams routinely borrow “substantial transformation” from customs/country-of-origin practice and from U.S. CBP origin determinations. That concept governs tariff origin. It does not govern EAR jurisdiction. BIS said so directly.

Where the analysis broke. In a footnote that no press account carried, BIS identified the exact misstep: “As is clear from 15 C.F.R. § 732.2(b)(3), if an exporter is exporting items from a foreign country, they should proceed to Step 3… If that item is of U.S. origin, the U.S. exporter should skip to Step 7 in § 732.3(b). Accordingly, AMAT should never have proceeded to Step 4 in § 732.2(d)” (Order pp. 11–12, fn. 15). Step 4 is the de minimis analysis. AMAT ran a de minimis calculation on an item that was U.S.-origin and therefore never eligible for that step; the correct path jumped straight to the license determination. The de minimis rules were doubly inapplicable: not only was the item U.S.-origin, but there was no “foreign-produced item” into which U.S. content could be “incorporated” (Order p. 13, citing 15 C.F.R. Part 734, Supp. 2, note to ¶(a)(1)).

A new operative gloss. BIS then articulated a standard that does not appear verbatim in the CFR: U.S.-origin items “are not rendered ‘foreign-made’ when the items are exported and then undergo further assembly and testing in a foreign country when, as here, those activities outside the United States involved little or no foreign-origin parts that were shipped to the foreign location from a non-U.S. location” (Order p. 12). The diagnostic phrase — “little or no foreign-origin parts… from a non-U.S. location” — is the line every Korean, Taiwanese, or Japanese assembler using U.S.-sourced kits needs to know exists, because it was used in a final consent order with precedential weight.

It is worth being precise about what BIS did not claim. The order excludes the Singapore-origin enclosure and factory interface from EAR liability: “Because these components were foreign-made and were not subject to the EAR under the de minimis or foreign direct product rules, neither the factory interface nor the enclosure were subject to the EAR” (Order p. 7). That exclusion is the analytical boundary a Korean SME can use to segment its own bill of materials: genuinely foreign-made sub-assemblies that clear de minimis and FDPR tests are not the problem. U.S.-origin content shipped from the U.S. for integration is.

3. What this means for Korean equipment makers

The order describes the production model in one sentence: AMAT would “partially produce ion implanting equipment… at its plant in Gloucester, Massachusetts upon receipt of an order from SMIC, then ship the partially assembled items and all required U.S.-origin and foreign-origin parts and components to South Korea to complete production… and then ship it from AMK in South Korea to SMIC in China” (Order p. 8).

Read that as a structural diagram, not a story about one company. U.S. partial build → Korean completion → China delivery is how many Korean equipment SMEs operate with U.S.-origin subsystems — vacuum chambers, RF generators, controllers, gas-delivery modules — sourced from U.S. OEMs, completed in Korea, and shipped to Chinese fabs. Any Korean firm that can map its own BOM onto that sentence is exposed.

Two further details sharpen the analogy. First, AMK was “primarily provided refurbishing services for ion implanters from a single facility in Pyeongtaek” before 2021 (Order p. 3) — it was repurposed from refurbishment into an assembly hub to serve the workaround. Korean subsidiaries and contract manufacturers recently asked by U.S. parents to expand assembly scope for China-bound orders are looking at their own AMK moment. Second, BIS was explicit that the offshoring structure itself is the violation: the regulatory analysis “did not change when, in order to continue selling to a single customer on the Entity List, AMAT established a process that partially moved assembly and testing activities outside the United States for specific items on which production had begun in the United States and that had been ordered by that single customer” (Order p. 11). The phrase “for specific items… ordered by that single customer” is the diagnostic test.

And the commercial pressure that drove the structure is documented as motive, not mitigation: losing SMIC “meant losing $112–150 million in annual revenue, and losing all of SMIC’s business meant a total negative economic impact of more than $1 billion per year” (Order p. 10). For a Korean SME whose China revenue is 30–50% of the total, the dependency that feels like a reason to keep shipping is precisely what BIS recorded as the reason the violation happened. The compliance conversation has to start there.

4. What this means for Chinese industrial buyers

Seen from the Chinese side, the case is a warning about supply-chain assumptions. SMIC received equipment it presumably believed was properly routed; it ended up at the center of a $252.5M enforcement action. A Chinese company sourcing components or tools from a Korean supplier cannot assume “Made in Korea” resolves U.S. licensing exposure. Whether a U.S. license is required turns on the component’s ECCN, the buyer’s regulatory status (Entity List, military-end-user), and whether U.S.-origin technology or equipment sits in the Korean production chain.

The practical implication for a Chinese buyer conducting due diligence on a Korean supplier — or a Chinese law firm advising one — is a documentation request: ask the Korean supplier for its export classification (ECCN or EAR99 determination), the license or license-exception basis for the specific transaction, and the U.S.-origin content path. The AMAT case is the reason those questions are now reasonable to ask, and reasonable for a Korean supplier to expect.

5. The audit timeline and the 1 July 2027 deadline

The order sets a compliance calendar that functions as a market clock for the entire Korean advisory space:

  • 25 September 2020 — BIS “is-informed” letter to AMAT: a license is required for ECCN 3B991 items to SMIC under § 744.21(b) (Order p. 4).
  • 18 December 2020 — SMIC added to the Entity List: a license required for all EAR items. The license universe expanded from specific ECCNs to everything in under three months, with no grace period (Order p. 4).
  • 11 February 2026 — Order effective; penalty of $252,500,300 due within 30 days (Order pp. 14, 19).
  • CY2026 — first internal audit period (1 Jan – 31 Dec 2026), covering all China-bound semiconductor-equipment exports, reexports, and in-country transfers.
  • 1 July 2027 — first audit report due to the BIS Boston Field Office (Order p. 15).
  • 1 July 2028 — second audit report due; the final scheduled deliverable (Order p. 15).
  • 11 February 2029 — end of the three-year suspended denial period; if payment and both audits are complete, the denial is waived. If either condition fails at any point, BIS may activate a fresh three-year denial order and revoke licenses in which AMAT has an interest (Order pp. 15–16).

The dates matter beyond AMAT. They establish what a post-settlement BIS audit regime looks like, and they give Korean equipment makers a concrete sense of the documentation depth a similar order would demand. The 14-month runway to the first audit report is, in effect, the planning horizon for any Korean firm that wants its controls in order before it is the subject of one.

6. Five implications for Korean compliance practice this quarter

  1. Retire “substantial transformation” from EAR analysis. It governs tariff origin, not EAR jurisdiction (Order p. 11). Any internal memo or external opinion that relies on Korean assembly to reset U.S.-origin status needs to be re-opened.
  2. Re-run EAR scope using the correct § 732.2 path. If an item is U.S.-origin, the analysis skips de minimis (Step 4) and proceeds to license determination (Order pp. 11–12, fn. 15). Confirm no product line is running a de minimis calculation it was never entitled to run.
  3. Segment the BOM against the AMAT boundary. Genuinely foreign-made sub-assemblies that clear de minimis and FDPR are outside the EAR (Order p. 7); U.S.-origin content shipped from the U.S. for integration is inside it. A rapid exposure assessment can be built on exactly this line.
  4. Treat an “is-informed” letter as a step-change event, not a routine notice. It can move from a single ECCN to the entire EAR universe in weeks (Order p. 4). (On what an is-informed letter does and does not obligate, see the companion guide on the BIS warning letter.)
  5. Map revenue concentration as a risk, not a defense. BIS documented SMIC dependency as the motive for the violation (Order p. 10). A China-revenue concentration of 30–50% is the conversation-opener with the board, not the reason to defer the conversation.

Appendix — verbatim quote reference

Every quotation above is from the BIS settlement documents (Order section, PDF pp. 1, 14–19; Proposed Charging Letter and Settlement Agreement cross-referenced where they add detail). The fifteen load-bearing quotes, with page citations, are maintained in the project’s primary-source extraction and were re-verified against the combined PDF before publication. The five most likely to be challenged by a sophisticated reader — the “substantial transformation” sentence (p. 11), the “hyper drive on [South] Korea” email (p. 8), the “little or no foreign-origin parts” standard (p. 12), the § 732.2 footnote (pp. 11–12, fn. 15), and the SOL tolling clause (SA ¶4, p. 17) — should each be quoted from the PDF, not from any summary, in derivative pieces.


A Korean-language version of this analysis will be published on Brunch, adapted for Korean SME compliance officers rather than translated. Companion short-form pieces cover the is-informed/warning letter mechanics, the Cadence EDA precedent, and what Chinese buyers should ask their Korean suppliers.